Goodwin Procter advised FountainVest Partners on the deal.FountainVest Partners announced the acquisition of China-based Beijing Zhendong Langdi Pharmaceutical Co., Ltd. for approximately US$900 million. FountainVest is now…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now